<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - FDA</title>
<description>International Business News - FDA</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>UPDATE 1-Pozen says US FDA accepts Vimovo marketing application</title>
  <description>Pozen Inc said U.S. health regulators have accepted a marketing application for its experimental pain drug Vimovo, triggering a $10 million milestone payment from AstraZeneca to Pozen.</description>
    <link>http://www.ibtimes.com/articles/20090831/update-pozen-says-us-fda-accepts-vimovo-marketing-application.htm</link> 
  <pubDate>Mon, 31 Aug 2009 10:43:53 EDT</pubDate>
  </item>


  <item>
  <title>UPDATE 2-US FDA staff question Allos lymphoma drug data</title>
  <description>WASHINGTON - U.S. drug reviewers questioned findings from biotech company Allos Therapeutics Inc (ALTH.O) on the effectiveness of its proposed drug for an aggressive type of lymphoma, documents released on Friday showed.</description>
    <link>http://www.ibtimes.com/articles/20090828/update-us-fda-staff-question-allos-lymphoma-drug-data.htm</link> 
  <pubDate>Fri, 28 Aug 2009 13:10:26 EDT</pubDate>
  </item>


  <item>
  <title>UPDATE 2-Eurand gets FDA nod for pancreatic enzyme product</title>
  <description>Aug 28 - Specialty pharmaceutical company Eurand NV (EURX.O) said U.S. health regulators approved its pancreatic enzyme product, Zenpep, to treat the inability to digest food due to a lack of enzymes made by the pancreas</description>
    <link>http://www.ibtimes.com/articles/20090828/eurand-gets-fda-nod-pancreatic-enzyme-product.htm</link> 
  <pubDate>Fri, 28 Aug 2009 09:19:06 EDT</pubDate>
  </item>


  <item>
  <title>UPDATE 1-US FDA staff question Genzyme leukemia drug study</title>
  <description>WASHINGTON - U.S. drug reviewers questioned a Genzyme Corp (GENZ.O) study meant to back wider use of the company's Clolar leukemia drug, according to documents released on Friday ahead of an advisory panel review.</description>
    <link>http://www.ibtimes.com/articles/20090828/us-fda-staff-question-genzyme-leukemia-drug-study.htm</link> 
  <pubDate>Fri, 28 Aug 2009 08:28:22 EDT</pubDate>
  </item>


  <item>
  <title>FDA requires additional labeling for OTC pain relievers and fever reducers</title>
  <description>The Food and Drug Administration issued a final rule Tuesday that requires manufactures of over-the-counter (OTC) products to revise their labeling including warnings about potential safety risks, such as internal bleeding and liver damage to help the consumers use products safely.</description>
    <link>http://www.ibtimes.com/articles/20090428/fda-requires-labeling-otc-pain-relievers-and-fever-reducers.htm</link> 
  <pubDate>Tue, 28 Apr 2009 20:12:32 EDT</pubDate>
  </item>


</channel>
</rss>